These results might be interpreted considering the vasoconstrictive effect ET-1 plays in the vasculature milieu, which has a recognized and relevant role in pulmonary hypertension since antagonists of its receptor are currently adopted in the pharmacotherapy of idiopathic pulmonary hypertension. The gene discussed is EDN1; the disease is pulmonary hypertension.